[Fibrinolytic therapy of deep venous thromboses. Prevention of post-thrombotic syndrome in the area of the pelvis and leg].
D004305:Dose-Response Relationship, Drug; D006801:Humans; D011186:Postphlebitic Syndrome / Q000517:prevention & control*; D013300:Streptokinase / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Fibrinolytische Therapie tiefer Venenthrombosen. Vermeidung des postthrombotischen Syndroms im Becken-Bein-Bereich.